Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Sarcoma 1Gastrointestinal 1

Conditions

Plexosarcoma 1Neoplasms 1Gastrointestinal Stromal Tumors 1Anemia, Iron-Deficiency 1Anemia 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Has results × Iron-Dextran Complex × Clear all
NCT02949947 2020-04-06

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 5 charts
Classical hematologyGastrointestinalSarcoma

Plexosarcoma, Anemia, Iron-Deficiency, Gastrointestinal Stromal Tumors

NCT00401544 2014-01-29

Darbepoetin Alfa With or Without Intravenous (IV) Iron

Amgen

Phase 2 Completed
243 enrolled 26 charts
Classical hematology

Anemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡